Logo image of BBIO

BRIDGEBIO PHARMA INC (BBIO) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:BBIO - US10806X1028 - Common Stock

75.15 USD
+1.09 (+1.46%)
Last: 12/12/2025, 8:15:17 PM
74.67 USD
-0.48 (-0.64%)
After Hours: 12/12/2025, 8:15:17 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
BBIO revenue by date.BBIO revenue by date.
77.65M
11.37%
9.303M
-88.02%
221.902M
2,285.27%
506.91M
128.44%
892.89M
76.14%
1.514B
69.56%
2.289B
51.19%
3.055B
33.46%
3.701B
21.15%
4.334B
17.10%
4.861B
12.16%
EBITDA
YoY % growth
BBIO ebitda by date.BBIO ebitda by date.
-461.66M
19.12%
-592.95M
-28.44%
-571.293M
3.65%
-476.991M
16.51%
-255.057M
46.53%
170.7M
166.93%
146.88M
-13.95%
535.5M
264.58%
934.32M
74.48%
1.32B
41.28%
1.646B
24.70%
EBIT
YoY % growth
BBIO ebit by date.BBIO ebit by date.
-468.43M
18.76%
-599.444M
-27.97%
-577.368M
3.68%
-506.178M
12.33%
-291.419M
42.43%
208.9M
171.68%
767.55M
267.42%
1.408B
83.44%
1.913B
35.87%
2.353B
23.00%
2.807B
19.29%
Operating Margin
BBIO operating margin by date.BBIO operating margin by date.
-603.26%-6,443.56%-260.19%-99.86%-32.64%13.80%33.53%46.09%51.69%54.29%57.75%
EPS
YoY % growth
BBIO eps by date.BBIO eps by date.
-3.11
20.46%
-3.94
-26.69%
-3.09
21.57%
-3.55
-14.87%
-1.86
47.65%
0.31
116.92%
4.81
1,429.95%
7.67
59.49%
10.51
36.97%
13.15
25.19%
15.36
16.75%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.76
46.03%
-0.69
21.39%
-0.59
38.21%
-0.48
49.15%
-0.48
36.78%
Revenue
Q2Q % growth
145.59M
2,375.18%
168.7M
44.64%
195.79M
77.08%
224.45M
85.96%
234.88M
61.33%
EBITDA
Q2Q % growth
-94.186M
56.25%
-62.258M
39.27%
-39.749M
69.63%
-38.534M
70.89%
N/A
EBIT
Q2Q % growth
-124.376M
43.81%
-105.065M
-1.22%
-86.008M
35.56%
-69.026M
49.38%
-41.548M
66.59%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.95
13.64%
-0.91-0.04-4.81%
Q2 2025
Q2Q % growth
-0.95
-143.59%
-0.86-0.09-10.44%
Q1 2025
Q2Q % growth
-0.88
-340.00%
-0.940.066.56%
Q4 2024
Q2Q % growth
-1.40
-45.83%
-1.15-0.25-21.38%
Q3 2024
Q2Q % growth
-1.10
-1.85%
-1.00-0.10-10.20%
Q2 2024
Q2Q % growth
-0.39
60.20%
-1.090.7064.07%
Q1 2024
Q2Q % growth
-0.20
78.26%
-0.780.5874.34%
Q4 2023
Q2Q % growth
-0.96
-4.35%
-0.93-0.03-3.37%
Q3 2023
Q2Q % growth
-1.08
-16.13%
-0.83-0.25-29.83%
Q2 2023
Q2Q % growth
-0.98
-1,300.00%
-0.85-0.13-15.29%
Q1 2023
Q2Q % growth
-0.92
22.69%
-0.85-0.07-8.52%
Q4 2022
Q2Q % growth
-0.92
8.91%
-0.87-0.05-5.84%
Q3 2022
Q2Q % growth
-0.93
12.26%
-1.010.088.30%
Q2 2022
Q2Q % growth
-0.07
89.39%
-0.640.5789.13%
Q1 2022
Q2Q % growth
-1.19
-0.85%
-1.13-0.06-5.11%
Q4 2021
Q2Q % growth
-1.01 -0.89-0.12-14.11%
Q3 2021
Q2Q % growth
-1.06
-8.16%
-0.92-0.14-15.33%
Q2 2021
Q2Q % growth
-0.66
35.92%
-0.960.3031.27%
Q1 2021
Q2Q % growth
-1.18
-51.28%
-0.75-0.43-56.60%
Q4 2020
Q2Q % growth
-1.01
-62.90%
-0.87-0.14-16.65%
Q3 2020
Q2Q % growth
-0.98
-92.16%
-0.94-0.04-4.43%
Q2 2020
Q2Q % growth
-1.03
70.23%
-0.79-0.24-30.80%
Q1 2020
Q2Q % growth
-0.78 -0.68-0.10-13.89%
Q4 2019
Q2Q % growth
-0.62 -0.710.0912.81%
Q3 2019
Q2Q % growth
-0.51 -0.560.059.37%
Q2 2019
Q2Q % growth
-3.46 -0.53-2.93-557.76%
BBIO Yearly EPS VS EstimatesBBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
120.7M
4,318.01%
108.51M12.19M11.23%
Q2 2025
Q2Q % growth
110.565M
4,999.86%
93.238M17.327M18.58%
Q1 2025
Q2Q % growth
116.633M
-44.76%
63.179M53.454M84.61%
Q4 2024
Q2Q % growth
5.882M
237.08%
3.549M2.333M65.74%
Q3 2024
Q2Q % growth
2.732M
-33.22%
3.837M-1.105M-28.80%
Q2 2024
Q2Q % growth
2.168M
32.11%
3.641M-1.473M-40.46%
Q1 2024
Q2Q % growth
211.12M
11,461.88%
14.314M196.806M1,374.92%
Q4 2023
Q2Q % growth
1.745M
-6.68%
6.353M-4.608M-72.53%
Q3 2023
Q2Q % growth
4.091M
1,103.24%
4.118M-27K-0.66%
Q2 2023
Q2Q % growth
1.641M
-97.77%
3.053M-1.412M-46.25%
Q1 2023
Q2Q % growth
1.826M
8.05%
3.443M-1.617M-46.96%
Q4 2022
Q2Q % growth
1.87M
-85.49%
4.615M-2.745M-59.48%
Q3 2022
Q2Q % growth
340K
-85.47%
8.063M-7.723M-95.78%
Q2 2022
Q2Q % growth
73.75M
36.52%
16.389M57.361M350.00%
Q1 2022
Q2Q % growth
1.69M
267.39%
4.789M-3.099M-64.71%
Q4 2021
Q2Q % growth
12.89M
10,641.67%
22.009M-9.119M-41.43%
Q3 2021
Q2Q % growth
2.34M
-71.22%
17.706M-15.366M-86.78%
Q2 2021
Q2Q % growth
54.02M 35.536M18.484M52.01%
Q1 2021
Q2Q % growth
460K 31.091M-30.631M-98.52%
Q4 2020
Q2Q % growth
120K
-99.13%
17.269M-17.149M-99.31%
Q3 2020
Q2Q % growth
8.13M
-69.60%
8.772M-642K-7.32%
BBIO Yearly Revenue VS EstimatesBBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.24% 7.05% 0.14% -3.47%
Revenue-1.62% 13.58% 2.29% 5.77%